Incorporation of a Theranostic "Two-Tone" Luminescent Silver Complex into Biocompatible Agar Hydrogel Composite for the Eradication of ESKAPE Pathogens in a Skin and Soft Tissue Infection Model

Inorganic Chemistry
Miguel N PintoPradip K Mascharak

Abstract

Microbial invasion and colonization of the skin and underlying soft tissues are among the most common types of infections, becoming increasingly prevalent in hospital settings. Systemic antibiotic chemotherapies are now extremely limited due to emergence of drug-resistant Gram-positive and multidrug-resistant Gram-negative bacterial strains. Topical administration of antimicrobials provides an effective route for the treatment of skin and soft tissue infections (SSTIs). Therefore, the development of new and effective materials for the delivery of these agents is of paramount importance. Silver is a broad-spectrum antibiotic used for the treatment and prevention of infections since ancient times. However, the high reactivity of silver cation (Ag+) makes its incorporation into delivery materials quite challenging. Herein we report a novel soft agar hydrogel composite for the delivery of Ag+ into infected wound sites. This material incorporates a Ag(I) complex [Ag2(DSX)2(NO3)2] (1; DSX = 5-(dimethylamino)- N, N-bis(pyridin-2-ylmethyl) naphthalene-1-sulfonamide) that exhibits a change in fluorescence upon Ag+ release and qualitatively indicates the end point of silver delivery. The antibacterial efficacy of the material was tested ...Continue Reading

References

Mar 1, 1987·Microbiological Reviews·B R Lyon, R Skurray
May 1, 1995·Journal of Wound Care·S S ThomasA Thomas
Jun 1, 1997·Journal of Clinical Microbiology·C WendtH Rüden
Sep 27, 2003·Journal of the American Academy of Dermatology·Nina Myerson FisherRossitza Lazova
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Giorgia BorrielloPhilip S Stewart
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew E Falagas, Sofia K Kasiakou
Jun 13, 2006·Current Problems in Dermatology·Alan B G Lansdown
Aug 9, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L Paterson
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul ScottBruno Petruccelli
Feb 8, 2008·The Journal of Antimicrobial Chemotherapy·K DriffieldI Chopra
Mar 19, 2008·Clinical Orthopaedics and Related Research·Jason H CalhounM M Manring
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Apr 9, 2009·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Vincent Ki, Coleman Rotstein
Jun 30, 2009·International Journal of Antimicrobial Agents·Matthew S Dryden
Oct 12, 2010·The Journal of Antimicrobial Chemotherapy·Matthew S Dryden
Oct 28, 2011·Burns : Journal of the International Society for Burn Injuries·Z AzizN J Chong
May 2, 2012·Virulence·Aoife HowardRoy D Sleator
May 15, 2012·Journal of the American Chemical Society·Brandon J HeilmanPradip K Mascharak
Jul 11, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A VieiraA Almeida
Dec 21, 2012·Angewandte Chemie·Svitlana Chernousova, Matthias Epple
Mar 6, 2013·Expert Review of Anti-infective Therapy·Jack N PendletonBrendan F Gilmore
May 15, 2013·Nature Reviews. Microbiology·Joseph A LemireRaymond J Turner
Sep 19, 2014·Perspectives in Medicinal Chemistry·Richard J Fair, Yitzhak Tor
Dec 30, 2014·Acta Crystallographica. Section A, Foundations and Advances·George M Sheldrick
Jan 9, 2015·Acta Crystallographica. Section C, Structural Chemistry·George M Sheldrick
Apr 24, 2015·Scientific Reports·Racheli Ben-Knaz WakshlakDavid Avnir
Jun 20, 2015·Journal of Applied Crystallography·Lennard KrauseDietmar Stalke
Sep 1, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amilcar F Cardona, Samuel E Wilson
Oct 27, 2015·Pharmacotherapy·Keith S Kaye, Jason M Pogue
May 28, 2016·Antimicrobial Agents and Chemotherapy·Patrick McGannKurt E Schaecher
Aug 12, 2016·Nature Reviews. Microbiology·Hans-Curt FlemmingStaffan Kjelleberg
Mar 28, 2017·Journal of the American Chemical Society·Upendar Reddy GAlexander Schiller
May 5, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Ignacio Barrasa-VillarJavier Moliner-Lahoz
Jun 24, 2017·Natural Product Reports·Andrew M Gulick
Feb 6, 2018·The Lancet Infectious Diseases·Madlen Davies, Timothy R Walsh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.